Tag: IVL
AVS completes US$36 million Series B financing ahead of IVL US...
Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financing of US$36 million. The funding will support the...
Boston Scientific to acquire IVL developer Bolt Medical
Boston Scientific has announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based...
Treatment of the common iliac arteries with Shockwave L6: Preserving future...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.
Ashish Patel (Guy’s and St Thomas’ NHS Foundation...
Changing the treatment mindset for calcified external iliac artery disease
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.
In this case report, Stefano Fazzini (University of...
Do we need to stent every calcified iliac lesion?
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.
Mark Portou (Royal Free Hospital, London, UK) presents...
A paradigm shift in the management of severe iliac calcification
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.
Charting the history of treatment for severely calcified...
Is it time to rethink your treatment strategy in calcified iliac...
This educational supplement is sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.
In this supplement:
Michel Bosiers (University Hospital Bern, Bern, Switzerland)...
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance...
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes associated with the Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter,...
Bolt Medical announces completion of RESTORE ATK and RESTORE BTK pivotal...
Bolt Medical has announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company's Bolt intravascular lithotripsy...
First patient enrolled in study of integrated laser atherectomy and IVL...
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy...
AVS enrols first patient in US pivotal intravascular lithotripsy study
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its US pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy....
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full US launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following...
AVS and Jacobs Institute partner on study of Pulse IVL system
Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (IVL) platform, recently announced it has entered into a strategic agreement with the Jacobs...
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave...
The Cardiovascular and Interventional Society of Europe (CIRSE) has announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on...
AVS receives IDE approval from US FDA for pivotal intravascular lithotripsy...
Amplitude Vascular Systems (AVS) announced today that it has received an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to...
Johnson & Johnson completes acquisition of Shockwave Medical
Johnson & Johnson today announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate...
FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology
FastWave Medical has announced the 30-day results of its first-in-human (FIH) study using the company's differentiated peripheral intravascular lithotripsy (IVL) technology.
This was a...
FastWave Medical secures multi-million dollar private financing within weeks
FastWave Medical recently announced the swift closure of an oversubscribed multi-million dollar private financing. A press release states that this achievement, secured in just...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
AVS’ pulsatile IVL technology attracts an additional US$8.8 million to close...
AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its pulsatile intravascular lithotripsy (PIVL) therapy, has...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical today announced the full US commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the US Food...
Shockwave IVL: A paradigm shift in the treatment of common femoral...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Raphaël Coscas (Ambroise Paré Hospital, AP-HP...
Shockwave IVL: The last piece of the puzzle to overcome the...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Giacomo Isernia and Gioele Simonte...
Shockwave IVL: Improving compliance is the key to “best endovascular” CFA...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
In this case report, Narayanan...
Shockwave IVL: Preserving options in no-stent zones
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Bella Huasen (Lancashire Teaching Hospitals...
Shockwave IVL: Sound science reinforced by sound evidence
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Stefano Fazzini (Tor Vergata Hospital,...
Change compliance to change the game in PAD treatment: Overcome the...
This educational supplement is sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
In this supplement:
Stefano Fazzini (Tor Vergata Hospital, Rome,...
Vascular News’ top 10 most popular stories of January 2023
January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...
Vascular News’ top 10 most popular stories of November 2022
November's top 10 includes the first results from BEST-CLI, as well as new data presented at this year's Vascular Interventional Advances (VIVA; 31 October–3...
Disrupt PAD III observational study results confirm safety and effectiveness of...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
Shockwave IVL: Maintaining options for patients with calcified PAD
Intravascular Lithotripsy (IVL; Shockwave Medical) gives physicians “the option to treat a patient efficiently without implanting something like a stent, which would limit further...
Shockwave IVL: Seeing is believing
Raphaël Coscas (Paris, France) talks to Vascular News about his introduction to Intravascular Lithotripsy (IVL; Shockwave Medical) and his initial experiences with the technology in...
Shockwave Medical and Genesis MedTech obtain regulatory approval in China for...
Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained approval from China’s National Medical Products Administration (NMPA) to market and...
Shockwave IVL maintains superiority to angioplasty in calcified peripheral disease at...
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to...
Confined by the complexity of calcium? Expand the boundaries with Shockwave...
This educational supplement is only available in selected countries and geographies.
In this supplement, sponsored by Shockwave Medical:
Marianne Brodmann (Medical University of...
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both CE mark and US...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
Vascular community needs a “clear strategy” for treating severely calcified lesions
Said Abisi (London, UK) talks to Vascular News about the various treatment options for peripheral arterial disease (PAD) patients with severely calcified lesions, including...
Cardiovascular Systems announces development of IVL technology for the treatment of...
Cardiovascular Systems recently announced that it has made significant progress towards the commercialisation of intravascular lithotripsy (IVL) systems for the treatment of calcific coronary...
Shockwave Medical enrols first patient in Disrupt BTK II study for...
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the...
CMS increases hospital outpatient payment for peripheral intravascular lithotripsy
Shockwave Medical has announced that, as part of the calendar year 2022 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule, the Centers for...
VIVA 2021: IVL “consistently” treats real-world calcium in multiple peripheral vessel...
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL; Shockwave Medical) performs “consistently well” across challenging peripheral vessels,...
